1 |
Akira, S. and H. Hemmi. 2003. Recognition of pathogen- associated molecular patterns by TLR family. Immunol. Lett. 85, 85-95.
DOI
ScienceOn
|
2 |
Araki, E., C. Forster, J. M. Dubinsky, M. E. Ross, and C. Iadecola. 2001. Cyclooxygenase-2 inhibitor NS-398 protects neuronal nultures from lipopolysaccharide-induced neurotoxicity. Stroke 32, 2370-2375.
DOI
ScienceOn
|
3 |
Chen, L. F. and W. C. Greene. 2004. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5, 392-401.
DOI
|
4 |
Vane, J. R., J. A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-Bailey, J. Croxtall, and D. A. Willoughby. 1994. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA 91, 2046-2050.
DOI
ScienceOn
|
5 |
Watters, J. J., J. A. Sommer, Z. A. Pfeiffer, U. Prabhu, A. N. Guerra, and P. J. Bertics. 2002. A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: the MEK/ERK pathway is not essential for nitric oxide and interleukin production. J. Biol. Chem. 277, 9077-9087.
DOI
|
6 |
Woo, M. S., S. H. Jung, J. W. Hyun, and H. S. Kim. 2004. Differential regulation of inducible nitric oxide synthase and cytokine gene expression by forskolin and dibutyryl-cAMP in lipopolysaccharide-stimulated murine BV2 microglial cells. Neurosci. Lett. 356, 187-190.
DOI
ScienceOn
|
7 |
Worrall, N. K., W. D. Lazenby, T. P. Misko, T. S. Lin, C. P. Rodi, P. T. Manning, R. G. Tilton, J. R. Williamson, and T. B. Ferguson. 1995. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J. Exp. Med. 181, 63-70.
DOI
ScienceOn
|
8 |
Lee, S. H., J. S. Han, S. J. Heo, J. Y. Hwang, and Y. J. Jeon. 2010. Protective effects of dieckol isolated from Ecklonia cava against high glucose-induced oxidative stress in human umbilical vein endothelial cells. Toxicol. In Vitro 24, 375-381.
DOI
ScienceOn
|
9 |
Kurumbail, R. G., A. M. Stevens, J. K. Gierse, J. J. Mcdonald, R. A. Stegeman, J. Y. Pak, D. Gildehaus, J. M. Miyashiro, T. D. Penning, K. Seibert, P. C. Lsakson, and W. C. Stallings. 1996. Structural basis for selective inhibition of cyclooxygenase- 2 by anti-inflammatory agents. Nature 384, 644-648.
DOI
ScienceOn
|
10 |
Lee, K. T., C. H. Ku, J. S. Eun, T. Y. Shin, J. P. Lim, D. O. Eom, O. P. Zee, and D. K. Kim. 2001. Antioxidative components from the aerial parts of Persicaria thunbergii. Arch. Pharm. Res. 6, 611-616.
|
11 |
Moncada, S., R. M. J. Plamer, and E. A. Higgs. 1991. Nitric Oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. 43, 109-142.
|
12 |
Nathan, C. and Q. W. Xie. 1994. Nitric oxide sythases: Roles, tolls, and controls. Cell 78, 915-918.
DOI
ScienceOn
|
13 |
St Clair, E. W., W. E. Wilkinson, T. Lang, L. Sanders, M. A. Misukonis, G. S. Gilkeson, D. S. Pisetaky, D. I. Granger, and J. B. Weinberg. 1996. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J. Exp. Med. 184, 1173-1178.
DOI
ScienceOn
|
14 |
Oh, H. M., B. M. Kwon, N. I. Baek, S. H. Kim, I. S. Chung, M. H. Park, H. W. Park, J. H. Lee, H. W. Park, E. J. Kim, and D. K. Kim. 2005. Inhibitory activity of isorhamnetin from Persicaria thunbergii on farnesyl protein transferase. Arch. Pharm. Res. 28, 169-171.
DOI
|
15 |
Perkins, N. D., and T. D. Gilmore. 2006. Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ. 13, 759-772.
DOI
ScienceOn
|
16 |
Paine, A., B. Eiz-Vesper, R. Blasczyk, and S. Immenschuh. 2010. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem. Pharmacol. 80, 1895-1903.
DOI
ScienceOn
|
17 |
Tak, P. P. and G. S. Firestein. 2001. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 107, 7-11.
DOI
ScienceOn
|
18 |
Cross, A. H., T. P. Misko, R. F. Lin, W. F. Hickey, J. L. Trotter, and R. G. Tilton. 1994. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93, 2684-2690.
DOI
ScienceOn
|
19 |
D'Aiuto, F., M. Parkar, G. Andreou, J. Suvan, P. M. Brett, D. Ready, and M. S. Tonetti. 2004. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J. Dent. Res. 83, 156-160.
DOI
ScienceOn
|
20 |
Garthwaite, J. 1995. Neural nitric oxide signaling. Trends Neurosci. 18, 51-52.
DOI
ScienceOn
|
21 |
Ghosh, S. and M. S. Hayden. 2008. New regulators of NF-kappaB in inflammation. Nat. Rev. Immunol. 8, 837-848.
DOI
ScienceOn
|
22 |
Jung, W. K., S. J. Heo, Y. J. Jeon, C. M. Lee, Y. M. Park, H. G. Byun, Y. H. Choi, S. G. Park, and I. W. Choi. 2009. Inhibitory effects and molecular mechanism of dieckol isolated from marine brown alga on COX-2 and iNOS in microglial cells. J. Agric. Food Chem. 57, 4439-4446.
DOI
ScienceOn
|
23 |
Gilmore, T. D. 2006. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25, 6680-6684.
DOI
ScienceOn
|
24 |
Gookin, J. L., S. Chiang, J. Allen, M. U. Armstrong, S. H. Stauffer, C. Finnegan, and M. P. Murtaugh. 2006. NF- mediated expression of iNOS promotes epithelial defense against infection by Cyptosporidium parvum in neonatal piglets. J. Physiol. 290, 164-174.
|
25 |
Hawkey, C. J. 1999. COX-2 inhibitors. Lancet. 353, 307-314.
DOI
ScienceOn
|
26 |
Kaisho, T. and S. Akira. 2006. Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 117, 979-987.
DOI
ScienceOn
|
27 |
Khazen, W., J. P. M'bika, C. Tomkiewicz, C. Benelli, C. Chany, A. Achour, and C. Forest. 2005. Expression of macrophage- selective markers in human and rodent adipocytes. FEBS. Lett. 579, 5631-5634.
DOI
ScienceOn
|